SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-014096
Filing Date
2024-02-14
Accepted
2024-02-14 16:40:26
Documents
53
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1223_citiuspharm.htm   iXBRL 10-Q 406290
2 CERTIFICATION f10q1223ex31-1_citiuspharma.htm EX-31.1 11022
3 CERTIFICATION f10q1223ex31-2_citiuspharma.htm EX-31.2 15718
4 CERTIFICATION f10q1223ex32-1_citiuspharma.htm EX-32.1 5875
  Complete submission text file 0001213900-24-014096.txt   3109238

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ctxr-20231231.xsd EX-101.SCH 42171
6 XBRL CALCULATION FILE ctxr-20231231_cal.xml EX-101.CAL 25410
7 XBRL DEFINITION FILE ctxr-20231231_def.xml EX-101.DEF 167328
8 XBRL LABEL FILE ctxr-20231231_lab.xml EX-101.LAB 348600
9 XBRL PRESENTATION FILE ctxr-20231231_pre.xml EX-101.PRE 176498
55 EXTRACTED XBRL INSTANCE DOCUMENT f10q1223_citiuspharm_htm.xml XML 265055
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38174 | Film No.: 24639493
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)